FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2026/01/100849 [Registered on: 12/01/2026] Trial Registered Prospectively
Last Modified On: 10/01/2026
Post Graduate Thesis  No 
Type of Trial  PMS 
Type of Study   Other (Specify) [Cosmetics]  
Study Design  Single Arm Study 
Public Title of Study   SkinQ Daily Gental Cleanser for Pollution mix Dirt 
Scientific Title of Study   An Open Label Clinick Study to evaluate the cleansing Efficacy of SkinQ Daily Gentle Cleanser for Pollution mix Dirt 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
CCFT1102 Version 1.0 dated 13 Dec 2025  Protocol Number 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Robin Chugh 
Designation  Principal Investigator 
Affiliation  CCFT Laboratories 
Address  CCFT Laboratories, Mittal Group Building, 121-B Mansarovar Industrial Estate, Panchli, Baghpat Road
Panchali
Meerut
UTTAR PRADESH
250005
India 
Phone  09027285265  
Fax    
Email  robinderm25@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Puneet Mittal 
Designation  Clinical Research Consultant  
Affiliation  CCFT Laboratories 
Address  CCFT Laboratories, Mittal Group Building, 121-B Mansarovar Industrial Estate, Panchli, Baghpat Road

Meerut
UTTAR PRADESH
250005
India 
Phone  08937015757  
Fax    
Email  puneetmittal@mgcts.org  
 
Details of Contact Person
Public Query
 
Name  Puneet Mittal 
Designation  Clinical Research Consultant  
Affiliation  CCFT Laboratories 
Address  CCFT Laboratories, Mittal Group Building, 121-B Mansarovar Industrial Estate, Panchli, Baghpat Road


UTTAR PRADESH
250005
India 
Phone  08937015757  
Fax    
Email  puneetmittal@mgcts.org  
 
Source of Monetary or Material Support  
CCFT Laboratories, Mittal Group Building, 121-B Mansarovar Industrial Estate, Panchli, Baghpat Road, Meerut, UTTAR PRADESH-250005  
Health Q Lifesciences Private Limited, SLI Solution Logistics LLP, Sohna Tauru Road, Indospace Building, Sehsaula, Ferozapur Jhirka, Nuh, Haryana 122104  
 
Primary Sponsor  
Name  Health Q Life Sciences Private Limited 
Address  SLI Solution Logistics LLP, Sohna Tauru Road, Indospace Building, Sehsaula, Ferozapur Jhirka, Nuh, Haryana 122104  
Type of Sponsor  Pharmaceutical industry-Indian 
 
Details of Secondary Sponsor  
Name  Address 
Not Applicable  Not Applicable 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Robin Chugh  CCFT laboratories  CCFT Laboratories, Mittal Group Building, 121-B Mansarovar Industrial Estate, Panchli, Baghpat Road Panchali
Meerut
UTTAR PRADESH 
09027285265

robinderm25@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
ARMHRC Institutional Ethics Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Healthy Human Volunteers  Not Applicable 
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Not Applicable  Not Applicable 
Intervention  Test Product: SkinQ Daily Gental Cleanser  Test Product: SkinQ Daily Gentle cleanser, Apply polution mix dirt on face evenly wait till it settle down on face. Route of administration: Topical, Duration: 30min  
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  45.00 Year(s)
Gender  Both 
Details  1) Gender: Male or Female 18 to 45
2) Subjects willing to give written informed
consent.
3) Volunteers with Normal to dry skin
4) Women of child bearing potential must have a negative urine pregnancy test prior to study entry.
5) Are free of any systemic or dermatologic disorder, which, in the opinion of the investigator, will interfere with the study
results or increase the risk of adverse events.
6) Are willing to avoid prolonged exposure of the treatment area to ultraviolet radiation (natural or artificial) for the duration of
the study.  
 
ExclusionCriteria 
Details  1. Subjects who are pregnant, breast-feeding, or planning to become pregnant during the study.
2. Use of systemic acne medications (e.g., oral isotretinoin within past 6 months) or topical prescription acne medications within 4 weeks.
2. Significant dermatologic conditions other than acne that could interfere with assessments.
3. Known sensitivity to product ingredients.
4. Recent facial procedures (chemical peels, lasers) within 4 weeks.
5. Have participated in any interventional clinical trial in the previous 90 days.
6. Have a known sensitivity to any of the constituents of the test product
7. Have used, are using, or are planning to use immunosuppressive or immunomodulatory medication (i.e., biologics), including corticosteroids.
8. Have not skin related issues. 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Change in pH
Change in TEWL
Dermascope imaging 
T0min, T+15 mins  
 
Secondary Outcome  
Outcome  TimePoints 
Not Applicable   Not Applicable  
 
Target Sample Size   Total Sample Size="32"
Sample Size from India="32" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Post Marketing Surveillance 
Date of First Enrollment (India)   22/01/2026 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="0"
Days="1" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   A single blind one arm study. 
Each participant entering the trial will be assigned to a regimen of investigational product to be used for removing the polution mix dirt.
 
Test product: SkinQ Daily Gental Cleanser for Pollution Mix Dirt/ SkinQ RX Skin balance Gentle cleanser
 
Assessments:
1.
 TEWL (Tewameter): (0, 15min) 
2. pH: (0, 15min)
3. Dermascope Imaging
 
Close